| __timestamp | Regeneron Pharmaceuticals, Inc. | Veracyte, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 2614539000 | 21584000 |
| Thursday, January 1, 2015 | 3711019000 | 28006000 |
| Friday, January 1, 2016 | 4560733000 | 39623000 |
| Sunday, January 1, 2017 | 5475166000 | 43758000 |
| Monday, January 1, 2018 | 6276700000 | 58930000 |
| Tuesday, January 1, 2019 | 7081200000 | 83845000 |
| Wednesday, January 1, 2020 | 7377200000 | 76028000 |
| Friday, January 1, 2021 | 13634200000 | 145114000 |
| Saturday, January 1, 2022 | 10612500000 | 194954000 |
| Sunday, January 1, 2023 | 11301400000 | 248148000 |
| Monday, January 1, 2024 | 12231500000 |
Infusing magic into the data realm
In the dynamic world of biotechnology, financial performance is a key indicator of a company's success and potential. Over the past decade, Regeneron Pharmaceuticals, Inc. has demonstrated a remarkable growth trajectory in gross profit, surging from approximately $2.6 billion in 2014 to over $11 billion by 2023. This represents an impressive increase of over 300%, underscoring Regeneron's robust market position and innovative prowess.
Conversely, Veracyte, Inc., while smaller in scale, has shown steady growth, with gross profits rising from around $21 million in 2014 to nearly $248 million in 2023. This tenfold increase highlights Veracyte's expanding footprint in the biotech sector.
The contrasting scales of these companies offer a fascinating insight into the diverse strategies and market dynamics within the biotechnology industry, where both giants and emerging players can thrive.
Johnson & Johnson vs Veracyte, Inc.: A Gross Profit Performance Breakdown
Gross Profit Analysis: Comparing Gilead Sciences, Inc. and Veracyte, Inc.
Vertex Pharmaceuticals Incorporated and Veracyte, Inc.: A Detailed Gross Profit Analysis
Who Generates Higher Gross Profit? Regeneron Pharmaceuticals, Inc. or Walgreens Boots Alliance, Inc.
Gross Profit Trends Compared: Regeneron Pharmaceuticals, Inc. vs Halozyme Therapeutics, Inc.
Regeneron Pharmaceuticals, Inc. vs Veracyte, Inc.: Efficiency in Cost of Revenue Explored
Analyzing R&D Budgets: Regeneron Pharmaceuticals, Inc. vs Veracyte, Inc.
Key Insights on Gross Profit: Regeneron Pharmaceuticals, Inc. vs BioCryst Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc. vs MiMedx Group, Inc.: A Gross Profit Performance Breakdown
Who Generates Higher Gross Profit? Takeda Pharmaceutical Company Limited or Veracyte, Inc.
Bio-Techne Corporation vs Veracyte, Inc.: A Gross Profit Performance Breakdown
Veracyte, Inc. and Supernus Pharmaceuticals, Inc.: A Detailed Gross Profit Analysis